Related Experiment Videos
Angiogenesis-dependent diseases and angiogenesis therapy.
1National Institute of Oncology, Department of Tumor Progression Ráth Gy. U. 7-9., Budapest, H1122, Hungary. 36 1 224 8786, 36 1 224 8620. jtimar@oncol.hu
Pathology Oncology Research : POR
|July 18, 2001
Summary
Understanding molecular mechanisms of blood vessel formation (angiogenesis) reveals two disease classes: those treatable by promoting angiogenesis and those by inhibiting it. Natural factors offer a promising future for treating angiogenesis-dependent diseases.
Area of Science:
- Biomedical research
- Molecular biology
- Vascular biology
Background:
- Physiological vasculogenesis and pathological angiogenesis are key molecular mechanisms underlying disease.
- Two distinct classes of diseases emerge: those treatable by promoting angiogenesis and those by inhibiting it.
Purpose of the Study:
- To highlight the dual role of angiogenesis in disease pathology.
- To explore the potential of natural pro- and anti-angiogenic factors in therapeutic strategies.
Main Methods:
- Review of molecular mechanisms in physiological and pathological angiogenesis.
- Analysis of therapeutic applications targeting angiogenesis.
- Evaluation of natural factors with angiogenic properties.
Main Results:
- Therapeutic angiogenesis can repair tissue damage in conditions like arteriosclerosis and limb ischemia.
- Inhibition of pathological angiogenesis is crucial for treating retinopathies and tumors.
- A growing number of synthetic antiangiogenic molecules exist.
Conclusions:
- Natural pro- and anti-angiogenic factors represent a more physiological approach for future treatments.
- Targeting angiogenesis offers therapeutic potential for a wide range of diseases.
- Further research into natural factors could revolutionize treatment for angiogenesis-dependent conditions.